$1.00
-0.03-3.10%
At close: Sep 18, 6:11 PM EDT
$0.969000
-0.03-3.10%
After Hours: 6:11 PM EDT
15 minutes delayed
Sonnet BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sonnet BioTherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.70 | $-0.76 | 7.89 % |
Mar 2024 | 2024-05-14 | $0.07 | $0.13 | -46.2 % |
Dec 2023 | 2024-02-14 | $-0.31 | $-0.90 | 65.6 % |
Sep 2023 | 2023-12-14 | $-0.78 | $-0.90 | 13.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $0 | $30.00K | -100.0 % |
Mar 2024 | 2024-05-14 | $0 | $10.00K | -100.0 % |
Dec 2023 | 2024-02-14 | $18.63K | $20.00K | -6.87 % |
Sep 2023 | 2023-12-14 | $37.26K | $20.00K | 86.3 % |
Sonnet BioTherapeutics (SONN) is scheduled to report earnings on December 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q3.
The Actual EPS was $-0.70, which beat the estimate of $-0.76.
The Actual Revenue was $0K, which missed the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.